To test if the LMP1-IKK2-TPL2-JNK pathway is also effective in PTLD, primary tumor cells were established in culture from tumor biopsies of two PTLD patients, resulting in PTLD099 and PTLD880 cells. The gene discussed is MAP3K8; the disease is post-transplant lymphoproliferative disease.